|
Index of reports
> Death (67)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 67 Next >>
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female
Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-12
Clolar
Dosage: 52 mg/m2, dose level 3
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-13
End date: 2012-07-17
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Clolar side effects in female
Reported by a physician from Australia on 2012-07-19
Patient: female
Reactions: Atrial Fibrillation, Febrile Neutropenia, Constipation, Delusion, Haemoglobin Decreased, Fatigue, Myocardial Infarction, Hallucination, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2010-10-25
End date: 2010-10-29
Clolar
Dosage: unk
Start date: 2010-11-29
End date: 2010-12-03
Other drugs received by patient: Metformin Hydrochloride
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: male, weighing 83.4 kg (183.5 pounds)
Reactions: Hepatic Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Acyclovir; Fluconazole; Ceftazidime; Filgrastim; Voriconazole
Possible Clolar side effects in 11 year old male
Reported by a physician from Argentina on 2012-06-14
Patient: 11 year old male
Reactions: Multi-Organ Failure, Cardiac Failure, Hypotension, Sepsis, Electrolyte Imbalance
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: unk
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: unk
Etoposide
Dosage: unk
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in male
Reported by a physician from United States on 2012-06-04
Patient: male, weighing 83.4 kg (183.5 pounds)
Reactions: Hyperbilirubinaemia, Hypoalbuminaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Voriconazole; Acyclovir; Ceftazidime; Filgrastim; Fluconazole
Possible Clolar side effects in 12 year old female
Reported by a physician from Argentina on 2012-05-25
Patient: 12 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-05-23
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Device Related Sepsis, Vomiting, Rash Erythematous, Febrile Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in 7 year old female
Reported by a physician from Argentina on 2012-05-15
Patient: 7 year old female
Reactions: Acute Lymphocytic Leukaemia, Pigmentation Disorder, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qdx5
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Etoposide
Dosage: 150 mg/m2, qdx5
Possible Clolar side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in male
Reported by a physician from United States on 2012-04-24
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Cardio-Respiratory Arrest, Mouth Haemorrhage, Unresponsive To Stimuli, Febrile Neutropenia, Pleural Effusion, Pancytopenia, Pneumonitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in female
Reported by a physician from United States on 2012-04-24
Patient: female, weighing 41.7 kg (91.7 pounds)
Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Stomatitis, Vomiting, Pain in Extremity, Nausea, Acute Lymphocytic Leukaemia, Renal Failure, Diarrhoea
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Promethazine; Vinorelbine; Zosyn; Linezolid; Amphojel; Meropenem; Nystatin; Norvasc; Octreotide Acetate; Dexamethasone; Vinorelbine; Caphosol; Vinorelbine; Pepcid; Zoloft; Bactrim; Caspofungin Acetate; Thiotepa; RED Blood Cells, Concentrated; Platelets; Allopurinol; Acyclovir; Solutions FOR Parenteral Nutrition; Oxycodone HCL; Neupogen; Ondansetron; Lorazepam; Zithromax; Vfend; Vancomycin; Octreotide Acetate; Topotecan; Cefepime; Imodium; Dexamethasone; D5 1 / 2 NS + KCL 20 MEQ / L; Imodium
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17
Patient: male, weighing 116.6 kg (256.5 pounds)
Reactions: Renal Failure, Pneumonia, Neutropenic Colitis, Neutropenic Sepsis, Hypotension, Pleural Effusion, Mental Status Changes, Staphylococcal Bacteraemia, Pulseless Electrical Activity
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Clolar
Dosage: 94 mg, once
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-29
End date: 2012-04-02
Busulfan
Dosage: 249 mg, once
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-03-31
Clolar
Indication: Bone Marrow Conditioning Regimen
Busulfan
Dosage: 390 mg, once
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-04-01
End date: 2012-04-02
Possible Clolar side effects in female
Reported by a physician from United States on 2012-04-11
Patient: female, weighing 41.7 kg (91.7 pounds)
Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Vomiting, Nausea, Pain in Extremity, Acute Lymphocytic Leukaemia, Mucosal Inflammation, Renal Failure, Diarrhoea
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: D5 1 / 2 NS + KCL 20 MEQ / L; Vfend; Pepcid; Zoloft; Solutions FOR Parenteral Nutrition; Imodium; Thiotepa; Ondansetron; Lorazepam; Vinorelbine; Vinorelbine; Zosyn; Zithromax; Norvasc; Bactrim; Octreotide Acetate; Oxycodone HCL; Acyclovir; Caphosol; Neupogen; Promethazine; Nystatin; Platelets; Cefepime; Imodium; RED Blood Cells, Concentrated; Allopurinol; Vinorelbine; Amphojel; Meropenem; Vancomycin; Dexamethasone; Dexamethasone; Topotecan; Linezolid; Caspofungin Acetate; Octreotide Acetate
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-04-09
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-04-03
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Clolar side effects in
Reported by a pharmacist from United States on 2012-04-02
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a pharmacist from United States on 2012-03-30
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a physician from United States on 2012-03-30
Patient:
Reactions: Death, Fall
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-03-30
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-03-30
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Clolar side effects in
Reported by a consumer/non-health professional from United States on 2012-03-29
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Clolar
Dosage: unk
Indication: Product Used FOR Unknown Indication
Possible Clolar side effects in 62 year old male
Reported by a physician from United States on 2012-03-28
Patient: 62 year old male, weighing 71.0 kg (156.2 pounds)
Reactions: Multi-Organ Failure, Sepsis, Acute Myeloid Leukaemia, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 37.2 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-24
Clolar
Dosage: 37.2 mg, unk
Start date: 2012-02-17
End date: 2012-02-17
Possible Clolar side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-28
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Transfusion-Related Acute Lung Injury, Sepsis, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, qdx5 consolidation
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-23
End date: 2012-01-27
Clolar
Dosage: cycle ii of induction
Start date: 2011-10-25
End date: 2011-10-28
Clolar
Dosage: cycle i of induction
Start date: 2011-10-04
End date: 2011-10-08
Other drugs received by patient: Ciprofloxacin HCL; Voriconazole; Oxycodone HCL; Ondansetron; Ondansetron; Compazine; Compazine
Possible Clolar side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-22
Patient: male, weighing 93.1 kg (204.8 pounds)
Reactions: Hypoxia, Acute Lymphocytic Leukaemia Recurrent, Cardiac Arrest, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 8000 mg
End date: 2012-03-06
Clolar
Dosage: 240 mg
End date: 2012-03-02
Possible Clolar side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-16
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Transfusion-Related Acute Lung Injury, Sepsis, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 20 mg/m2, qdx5 consolidation
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-23
End date: 2012-01-27
Clolar
Dosage: cycle i of induction
Start date: 2011-10-04
End date: 2011-10-08
Clolar
Dosage: cycle ii of induction
Start date: 2011-10-25
End date: 2011-10-28
Other drugs received by patient: Voriconazole; Ondansetron; Ondansetron; Compazine; Oxycodone HCL; Compazine; Ciprofloxacin Hydrochloride
Possible Clolar side effects in
Reported by a physician from United States on 2012-03-09
Patient:
Reactions: Death, Fall
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Page 1 Next >>
|
